Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.47 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.47 |
| ▸ | BID | P55957 | 3/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.45 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.45 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.45 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6430932 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL10929933 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL29482422 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL6430930 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL31697675 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL31422636 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL10716367 | 1.00 | PTGS2 (0.56) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL7045769 | 0.98 | PTGS2 (0.54) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL2532475 | 0.98 | PTGS2 (0.54) | PTGS2ALOX5PPARAPPARGLIPG | |
| SCHEMBL6669409 | 0.98 | PTGS2 (0.54) | PTGS2ALOX5PPARAPPARGLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005854-A | High-temperature-resistant profile control plugging agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117548308-A | Preparation method of self-cleaning nano transparent heat-insulating coating | 森宝科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-115135307-A | Carrier for cell delivery | 株式会社ITO | 2022-09-30 | — | — | CN | claimed |
| CN-112708347-B | Preparation method and application method of light self-cleaning, fluoride-free and waterproof multifunctional nano sol | 森宝科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-113563509-B | Composition for preparing fracturing thickening agent, fracturing thickening agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113563509-A | Composition for preparing fracturing thickening agent, fracturing thickening agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-10-29 | — | — | CN | claimed |
| EP-2773426-B1 | COMBINATIONAL LIPOSOME COMPOSITIONS FOR CANCER THERAPY | MALLINCKRODT LLC (US) | 2018-08-22 | — | — | EP | claimed |
| EP-2162575-B1 | A LYOCELL FIBER WITH MODIFIED PROPERTY AND A PROCESS FOR MAKING THEREFOR | ADITYA BIRLA SCI & TECH CO LTD (IN) | 2013-03-13 | — | — | EP | claimed |
| US-8338087-B2 | Composition and process for post-etch removal of photoresist and/or sacrificial anti-reflective material deposited on a substrate | ADVANCED TECHNOLOGY MATERIALS, INC (US) | 2012-12-25 | — | — | US | claimed |
| EP-2162574-B1 | A VISCOSE FIBER WITH MODIFIED PROPERTY AND A PROCESS FOR MAKING THEREFOR | ADITYA BIRLA SCI & TECH CO LTD (IN) | 2012-09-05 | — | — | EP | claimed |
| EP-2162488-B1 | ACRYLIC FIBER WITH MODIFIED PROPERTY AND A PROCESS FOR MAKING THEREFOR | ADITYA BIRLA SCI & TECH CO LTD (IN) | 2012-09-05 | — | — | EP | claimed |
| EP-1164124-B1 | Aqueous suspensions of pentabromobenzyl acrylate | BROMINE COMPOUNDS LTD (IL) | 2006-10-18 | — | — | EP | claimed |
| EP-0970990-B1 | Colored polyester thermoplastic materials comprised of poly(oxyalkylenated) compounds as colorants and specific surfactants as diluents | MILLIKEN & CO (US) | 2004-03-31 | — | — | EP | claimed |
| EP-1164124-A2 | Aqueous suspensions of pentabromobenzyl acrylate | Bromine Compounds Ltd. (IL) | 2001-12-19 | — | — | EP | claimed |
| EP-0970990-A1 | Colored polyester thermoplastic materials comprised of poly(oxyalkylenated) compounds as colorants and specific surfactants as diluents | Milliken & Company (US) | 2000-01-12 | — | — | EP | claimed |
| US-5973064-A | PROVIDING COLORATION TO POLYESTER THERMOPLASTIC MATERIAL DURING EXTRUSION OR INJECTION MOLDING PROCEDURE | MILIKEN RESEARCH CORPORATION | 1999-10-26 | — | — | US | claimed |
| EP-0168059-B1 | GLASS FIBER REINFORCED VINYL CHLORIDE POLYMER PRODUCTS AND PROCESS FOR THEIR PREPARATION | The B.F. GOODRICH Company (US) | 1990-05-02 | — | — | EP | claimed |
| US-12551527-B2 | Drug delivery systems for treatment of infections | WAYNE STATE UNIVERSITY (US) | 2026-02-17 | — | — | US | disclosed |
| EP-0083768-A1 | Flame resistant resin composition | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1983-07-20 | — | — | EP | disclosed |
| EP-0062138-A1 | Aqueous coating material | HÜLS AKTIENGESELLSCHAFT (DE) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551527-B2 | Drug delivery systems for treatment of infections | PHOSPHO1, PCTP, SGMS1 | PTGS2 3891/4885ALOX5 4569/4885PPARA 2365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.